BackSanten Pharmaceutical , Ltd. Overview

Santen Pharmaceutical , Ltd. Total Assets

Track Santen Pharmaceutical , Ltd.'s total assets ($410B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$412.84B
↑ 1.16% YoYΔ $4.72B vs prior year quarter

Peer trimmed avg / median

Loading

Santen Pharmaceutical , Ltd. Total Assets History

Loading

Santen Pharmaceutical , Ltd. vs. peers: Total Assets Comparison

Loading

Santen Pharmaceutical , Ltd. Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Santen Pharmaceutical , Ltd. (SNPHY) FAQ

As of the most recent data (June 2026), SNPHY shows a total assets of $410B. That compares with $410B in the prior-year period — up 1.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SNPHY's total assets is now $410B (was $410B) — a 1.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Santen Pharmaceutical , Ltd. is outperforming or lagging.

Tracking SNPHY's total assets over time shows whether Santen Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $410B That compares with $410B in the prior-year period — up 1.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Santen Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $410B) with ownership activity and broader fundamentals.